Valuation: Jamjoom Pharmaceuticals Factory Company

Market Cap 9.89B 2.63B 2.28B 2.13B 1.95B 3.67B 251B 3.73B 24.99B 9.81B 126B 9.68B 419B P/E 2026 *
19x
P/E 2027 * -
Enterprise Value 9.57B 2.55B 2.21B 2.06B 1.89B 3.55B 243B 3.61B 24.19B 9.49B 122B 9.37B 405B EV / Sales 2026 *
5.92x
EV / Sales 2027 * 5.07x
Free-Float
38.61%
Yield 2026 *
3.17%
Yield 2027 * 3.52%

Last Transcript: Jamjoom Pharmaceuticals Factory Company

1 day-0.57%
1 week-0.57%
Current month+2.70%
1 month-4.94%
3 months-9.35%
6 months+9.00%
Current year-1.26%
1 week 138.8
Extreme 138.8
143.5
1 month 134.5
Extreme 134.5
148.9
Current year 125
Extreme 125
163.7
1 year 125
Extreme 125
165.3
3 years 100.2
Extreme 100.2
202.4
5 years 66
Extreme 66
202.4
10 years 66
Extreme 66
202.4
Manager TitleAgeSince
Chief Executive Officer 62 2021-05-14
Director of Finance/CFO 62 2013-01-12
Chief Operating Officer 31 2021-08-31
Director TitleAgeSince
Chairman 66 2022-06-18
Director/Board Member 41 2022-06-18
Director/Board Member 98 2022-06-18
Change 5-day change 1-year change 3-year change Capi.($)
-0.57%-0.57%-12.95%+20.70% 2.63B
-0.12%-1.12%+20.74%+71.50% 48.92B
-1.14%+9.22%+60.80%+124.81% 41.53B
-0.32%+0.21%-2.78%+17.02% 12.43B
+6.43%+5.40%+24.64%+82.96% 11.7B
+0.19%-0.38%+30.98%+137.44% 9.09B
0.00%+6.95%+22.88%+37.42% 7.4B
+1.62%+3.49%+41.67%-13.45% 7.15B
+1.10%+2.29%+11.06%+184.02% 6.66B
+0.03%+8.55%-24.59%+30.34% 5.95B
Average +0.71%+3,378.61%+17.25%+69.28% 15.35B
Weighted average by Cap. +0.24%+4,940.50%+28.90%+83.11%

Financials

2026 *2027 *
Net sales 1.62B 431M 373M 348M 318M 600M 41.07B 610M 4.09B 1.6B 20.55B 1.58B 68.43B 1.87B 498M 431M 403M 368M 694M 47.52B 705M 4.73B 1.86B 23.77B 1.83B 79.18B
Net income 521M 139M 120M 112M 103M 193M 13.23B 196M 1.32B 517M 6.62B 510M 22.05B -
Net Debt -317M -84.42M -73.09M -68.31M -62.43M -118M -8.05B -119M -801M -314M -4.03B -310M -13.42B -404M -108M -93.14M -87.06M -79.57M -150M -10.26B -152M -1.02B -401M -5.13B -395M -17.1B
Logo Jamjoom Pharmaceuticals Factory Company
Jamjoom Pharmaceuticals Factory Company SJSC is a Saudi Arabia-based pharmaceutical company, which is primarily focused on developing, manufacturing, and distributing generic pharmaceuticals, cosmetics, and consumer healthcare products. It produces human medicines, nutraceuticals, antibiotics, general analgesics, medicines for treatment of cough, allergy, asthma, heart diseases, blood pressure, diarrhoea, vomiting, and ulcer and acidity, among others. It operates in two segments: The Pharmaceutical products that represents medicines or drugs for the prevention and treatment of diseases, and protection of public health; and The Consumer health products that represents products used to support personal well-being, maintain health, or address specific health-related needs. The Company’s subsidiaries include Al Jamjoom Pharma for Pharmaceutical Industries and Jamjoom Pharmaceutical Industry and Commerce Company Limited and the Company also operates approximately 8 branches.
Employees
-
Date Price Change Volume
26-08-11 SAR 140.50 -0.57% 6,681
26-08-10 SAR 141.30 +0.93% 59,877
26-08-09 SAR 140.00 -0.07% 6,701
26-08-06 SAR 140.10 -1.34% 17,729
26-08-05 SAR 142.00 +0.50% 22,205
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
141.30SAR
Average target price
164.24SAR
Spread / Average Target
+16.24%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4015 Stock